Connected Magazine

Brian O’Callaghan to lead Canadian AI drug firm

Irishman will be responsible for leading biotech Deep Genomic’s next stage of growth

Brian O’Callaghan, chief executive of Deep Genomics: ‘I look forward to leading Deep Genomics into the next phase of growth and working with such a visionary and committed team’

Irish life sciences veteran Brian O’Callaghan has taken the reins at Canadian AI drug development firm Deep Genomics.

O’Callaghan, who has held c-suite and board positions in several pharma companies, was recently appointed chief executive of the Toronto-based company.

Deep Genomics, founded in 2015 and spun out of the University of Toronto, is a biotech start-up backed by Softbank that is working with artificial intelligence to analyse genetic data to develop new drugs.

It works ...